Opsonin pharma
-
Upload
sabbir-ahmed -
Category
Health & Medicine
-
view
73 -
download
0
Transcript of Opsonin pharma
![Page 1: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/1.jpg)
![Page 2: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/2.jpg)
Sabbir Ahmed142-11-3962
![Page 3: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/3.jpg)
OVERVIEW Opsonin Pharma Ltd. (OPL) develops,
manufactures and markets generic medicines for human use.
![Page 4: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/4.jpg)
MISSION
![Page 5: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/5.jpg)
MARKET SHARE OF COMPANIES
Serial Pharma Tk (Crore) Market Share
Growth %
01 Square 1378 19.18 23.54
02 Incepta 650 9.05 32.17
03 Beximco 620 8.62 40.33
04 Opsonin 355 4.94 26.09
05 Eskayef 348 4.84 24.82
![Page 6: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/6.jpg)
Hasan Sikder 142-11-3954
![Page 7: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/7.jpg)
PRODUCTION FACIALITY:
Opsonin Pharma Ltd. operates on 350,000 square feet of manufacturing area.
4000 stakeholders. Opsonin Group employs more than 6000
people.
![Page 8: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/8.jpg)
QUALITY ASSURANCE: Quality Assurance procedures ensure
that the quality of products are maintained.packaging materials and finished product.
![Page 9: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/9.jpg)
Sharmin Afroz 142-11-3963
![Page 10: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/10.jpg)
S.W.O.T• Well diversifies• Strong R & DStrength
• Insufficient working capital.
• Net operating in low cost market.
Weakness
![Page 11: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/11.jpg)
Can add more products to its PFModern Technological advantages
Opportunity Fulfilling the
due commitments
Open market competition
Threat
![Page 12: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/12.jpg)
Farida Hakim 142-11-3980
![Page 13: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/13.jpg)
PESTEL ANALYSIS: Political Factors
Economic Factors
![Page 14: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/14.jpg)
Environmental Factors
Legal Factors
![Page 15: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/15.jpg)
Safia Akther 142-11-3774
![Page 16: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/16.jpg)
PORTER’S 5 FORCE ANALYSIS:
Bargain Power Of Customer. Bargain Power of Supplier. Rivalry Among Existing Firms. Threat of Substitute Products. Threat of new Entrants.
![Page 17: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/17.jpg)
Fahimul Haq 142-11-3968
![Page 18: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/18.jpg)
PORTER’S 5 FORCE ANALYSIS
Buye
r
Supp
lier
Compe
tition
Subst
itute
New En
trants
0%40%80%
Very LowLowModerateHighVery High
Very High High Moderate Low Very LowBuyer 0 0 2 7 3
Supplier 0 2 2 5 3Competitor 1 5 3 2 1Substitute 0 0 3 4 5
New Entrant 6 3 2 1 0
A Small survey on 12 professional shows the following result
![Page 19: Opsonin pharma](https://reader036.fdocuments.in/reader036/viewer/2022062902/58f9aaf11a28ab6d4a8b45a1/html5/thumbnails/19.jpg)
CONCLUSION:
The pharmaceutical industry is highly complex. The technologies leading to drug discovery and development are at the limits of human knowledge.